Skip to search formSkip to main contentSkip to account menu

Neomercazole

Known as: Neo-Mercazole, Roche Brand of Carbimazole, neo mercazole 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

Antithyroid AgentsCarbimazole

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
L’exophtalmie basedowienne
2007
2007
Myelodysplastic syndrome and pancytopenia responding to treatment of hyperthyroidism: peripheral blood and bone marrow analysis before and after antihormonal treatment.
Hematological disorders, especially single lineage abnormalities, have been described in hyperthyroidism. Pancytopenia has been… 
2005
2005
Thyrotoxic periodic paralysis in Caucasian patients: a diagnostic challenge.
2004
2004
Paroxysmal kinesigenic dyskinesia manifestation of hyperthyroidism.
Sporadic paroxysmal kinesigenic dyskinesia (PKD) secondary to thyrotoxicosis is an extremely rare entity. A 36-year-old female… 
2003
2003
Hyperthyroïdie post-radique : une complication rare du traitement des cancers de l’enfant
2002
2002
Aplasia cutis congenita and antithyroid drugs.
  • R. IzharT. Ghani
  • JPMA. The Journal of the Pakistan Medical…
  • 2002
  • Corpus ID: 34345574
1999
1999
Subclinical hyperthyroidism and hyperkinetic behavior in children.
1970
1970
Apathetic thyrotoxicosis.
A 66-year-old male patient presented to the hospital with the complaints of weakness, loss of weight of about 10 kg in 2 months… 
1953
1953
Treatment of thyrotoxicosis with neo mercazole (2-carbethoxythio-1-methylglyoxaline; report of 120 cases.
1953
1953
Thyrotoxicosis treated with 2-carbethoxythio-1-methylglyoxaline (neo mercazole).
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)